Schwab Charles Investment Management Inc. increased its stake in Thermo Fisher Scientific Inc (NYSE:TMO) by 3.6% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,401,991 shares of the medical research company’s stock after buying an additional 48,941 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Thermo Fisher Scientific were worth $215,346,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. First American Bank raised its position in shares of Thermo Fisher Scientific by 47.8% in the first quarter. First American Bank now owns 23,488 shares of the medical research company’s stock valued at $3,608,000 after buying an additional 7,596 shares during the period. Univest Corp of Pennsylvania bought a new position in shares of Thermo Fisher Scientific during the first quarter valued at approximately $3,133,000. Legacy Private Trust Co. raised its position in shares of Thermo Fisher Scientific by 2.0% in the first quarter. Legacy Private Trust Co. now owns 29,108 shares of the medical research company’s stock valued at $4,471,000 after buying an additional 567 shares during the period. Bank of Montreal Can raised its position in shares of Thermo Fisher Scientific by 4.7% in the first quarter. Bank of Montreal Can now owns 223,879 shares of the medical research company’s stock valued at $34,388,000 after buying an additional 10,125 shares during the period. Finally, Ipswich Investment Management Co. Inc. raised its position in shares of Thermo Fisher Scientific by 0.3% in the first quarter. Ipswich Investment Management Co. Inc. now owns 9,285 shares of the medical research company’s stock valued at $1,426,000 after buying an additional 30 shares during the period. 87.15% of the stock is owned by hedge funds and other institutional investors.

Shares of Thermo Fisher Scientific Inc (NYSE:TMO) traded up 0.87% on Friday, hitting $173.23. 2,202,642 shares of the stock traded hands. Thermo Fisher Scientific Inc has a 12-month low of $139.07 and a 12-month high of $182.87. The stock has a market cap of $67.58 billion, a price-to-earnings ratio of 30.18 and a beta of 1.06. The stock has a 50-day moving average price of $176.78 and a 200 day moving average price of $165.46.

Thermo Fisher Scientific (NYSE:TMO) last released its quarterly earnings results on Wednesday, July 26th. The medical research company reported $2.30 EPS for the quarter, beating the Zacks’ consensus estimate of $2.27 by $0.03. Thermo Fisher Scientific had a net margin of 11.80% and a return on equity of 15.97%. The company had revenue of $5 billion for the quarter, compared to analyst estimates of $4.92 billion. During the same quarter last year, the firm posted $2.03 earnings per share. The company’s quarterly revenue was up 10.2% compared to the same quarter last year. On average, analysts anticipate that Thermo Fisher Scientific Inc will post $9.24 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Monday, October 16th. Stockholders of record on Friday, September 15th will be given a $0.15 dividend. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.35%. The ex-dividend date of this dividend is Thursday, September 14th. Thermo Fisher Scientific’s dividend payout ratio is 10.45%.

COPYRIGHT VIOLATION NOTICE: “Thermo Fisher Scientific Inc (NYSE:TMO) Shares Bought by Schwab Charles Investment Management Inc.” was originally posted by Watch List News and is the sole property of of Watch List News. If you are reading this piece of content on another publication, it was stolen and republished in violation of U.S. and international copyright law. The original version of this piece of content can be viewed at https://www.watchlistnews.com/thermo-fisher-scientific-inc-nysetmo-shares-bought-by-schwab-charles-investment-management-inc/1479079.html.

Several equities analysts recently commented on TMO shares. Leerink Swann set a $187.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, April 27th. Barclays PLC set a $175.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Wednesday, April 26th. BTIG Research upped their price target on shares of Thermo Fisher Scientific from $180.00 to $190.00 and gave the stock a “buy” rating in a research report on Friday, April 28th. Deutsche Bank AG upped their price target on shares of Thermo Fisher Scientific from $163.00 to $188.00 and gave the stock a “buy” rating in a research report on Friday, April 28th. Finally, Jefferies Group LLC increased their price objective on shares of Thermo Fisher Scientific from $160.00 to $175.00 and gave the stock a “hold” rating in a research report on Friday, April 28th. One research analyst has rated the stock with a hold rating, sixteen have given a buy rating and one has assigned a strong buy rating to the company. Thermo Fisher Scientific presently has a consensus rating of “Buy” and an average price target of $188.56.

In other news, CEO Marc N. Casper sold 20,000 shares of Thermo Fisher Scientific stock in a transaction that occurred on Thursday, June 1st. The shares were sold at an average price of $172.79, for a total value of $3,455,800.00. Following the transaction, the chief executive officer now owns 269,279 shares of the company’s stock, valued at $46,528,718.41. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, CFO Stephen Williamson sold 2,500 shares of Thermo Fisher Scientific stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $176.26, for a total transaction of $440,650.00. Following the completion of the transaction, the chief financial officer now directly owns 37,790 shares in the company, valued at approximately $6,660,865.40. The disclosure for this sale can be found here. In the last three months, insiders sold 27,188 shares of company stock worth $4,702,223. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Company Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Want to see what other hedge funds are holding TMO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc (NYSE:TMO).

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.